Meyers James R 4
4 · Arbutus Biopharma Corp · Filed May 26, 2023
Insider Transaction Report
Form 4
Meyers James R
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-05-24+55,000→ 55,000 totalExercise: $2.56From: 2023-05-24Exp: 2033-05-24→ Common Shares (55,000 underlying)
Footnotes (2)
- [F1]Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on May 24, 2023, the date of the grant.
- [F2]The option is fully vested and exercisable as of the date of the grant.